We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
(+10%)
Cap. Flow
+$812M
Cap. Flow
% of AUM
7.54%
Top 10 Holdings %
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$32.7M |
| 2 |
Eli Lilly
LLY
|
+$31M |
| 3 |
La-Z-Boy
LZB
|
+$17.4M |
| 4 |
Ubiquiti
UI
|
+$17.1M |
| 5 |
TriMas Corp
TRS
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LSB Industries
LXU
|
+$14M |
| 2 |
K
Kellanova
K
|
+$13.7M |
| 3 |
Apple
AAPL
|
+$13.1M |
| 4 |
Prosperity Bancshares
PB
|
+$11.7M |
| 5 |
Fluor
FLR
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.72% |
| 2 | Industrials | 12.7% |
| 3 | Healthcare | 12.22% |
| 4 | Financials | 10.93% |
| 5 | Energy | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
McCormick & Company Non-Voting
MKC
$13.4B
| $8.11M | 0.08% |
226,228
+70,004
| +45% | +$2.36M |
|
327
Nasdaq
NDAQ
$51.5B
| $8.06M | 0.07% |
654,552
+4,173
| +0.6% | +$53.9K |
|
328
KLA
KLAC
$275B
| $8M | 0.07% |
1,156,690
+133,490
| +13% | +$864K |
|
|
RHT
329
DELISTED
Red Hat Inc
RHT
| $7.94M | 0.07% |
149,862
| – | – |
|
330
Energy Transfer Partners
ET
$70.1B
| $7.88M | 0.07% |
337,126
-85,230
| -20% | -$1.84M |
|
331
Trane Technologies
TT
$106B
| $7.86M | 0.07% |
137,423
-32,730
| -19% | -$1.95M |
|
332
Allstate
ALL
$66.9B
| $7.84M | 0.07% |
138,682
-49,102
| -26% | -$2.63M |
|
333
iShares MSCI EAFE Value ETF
EFV
$27.6B
| $7.83M | 0.07% |
136,005
+8,606
| +7% | +$486K |
|
334
Globus Medical
GMED
$10.4B
| $7.74M | 0.07% |
291,141
-13,500
| -4% | -$321K |
|
335
Graco
GGG
$12.9B
| $7.7M | 0.07% |
308,955
+240
| +0.1% | +$6K |
|
336
Genuine Parts
GPC
$17.1B
| $7.59M | 0.07% |
87,453
+72,520
| +486% | +$6.12M |
|
|
RPT
337
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $7.56M | 0.07% |
464,169
-232,847
| -33% | -$3.73M |
|
338
Sonoco
SON
$5.76B
| $7.53M | 0.07% |
183,662
+55,593
| +43% | +$2.31M |
|
339
TE Connectivity
TEL
$58.8B
| $7.52M | 0.07% |
124,868
-13,734
| -10% | -$788K |
|
340
Oshkosh
OSK
$9.67B
| $7.51M | 0.07% |
127,687
+42,978
| +51% | +$2.36M |
|
341
WEC Energy
WEC
$37.7B
| $7.5M | 0.07% |
161,075
+10,080
| +7% | +$434K |
|
342
Lincoln Electric
LECO
$13.8B
| $7.49M | 0.07% |
104,016
+15,160
| +17% | +$1.09M |
|
|
LNKD
343
DELISTED
LinkedIn Corporation
LNKD
| $7.48M | 0.07% |
40,462
-480
| -1% | -$98.4K |
|
344
Cigna
CI
$76.6B
| $7.46M | 0.07% |
89,096
-5,408
| -6% | -$445K |
|
345
Analog Devices
ADI
$181B
| $7.43M | 0.07% |
139,853
+12,352
| +10% | +$623K |
|
346
Microchip Technology
MCHP
$42.8B
| $7.41M | 0.07% |
310,360
-158,184
| -34% | -$3.61M |
|
347
MYR Group
MYRG
$5.9B
| $7.41M | 0.07% |
292,764
+48,793
| +20% | +$1.19M |
|
348
Community Trust Bancorp
CTBI
$1.38B
| $7.34M | 0.07% |
194,747
+32,521
| +20% | +$1.21M |
|
349
Williams-Sonoma
WSM
$26.7B
| $7.27M | 0.07% |
218,330
+214,160
| +5,136% | +$6.24M |
|
|
STJ
350
DELISTED
St Jude Medical
STJ
| $7.27M | 0.07% |
111,220
+3,046
| +3% | +$198K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2014 Portfolio in Review
As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.
- Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
- Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
- Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
- Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
- Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
- Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
- Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.
Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.